ANNX · Annexon, Inc.
$5.07
-0.12 (-2.22%)
At close · Aug 21
Market Cap
$1.06B
Shares
204.44M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.18
Open$5.41
Day$5.11–5.47
52W close$2.05–6.96
Avg vol 30d3.1M
Short int30.8M · 15.1% float · 10.5d
Short vol47%
Last earningsAug 12, 2026
DataJul 2020–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−2%
below
Price vs 50-day avg
−3%
below
RSI (14)
46
neutral
MACD trend
Positive
52-week position
64%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−2%
trailing
6-month return
−8%
trailing
YTD return
+3%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +30 funds added
Insider flow
Accumulating
Net +$3.3M over 90 days · 0% sells
Short interest
Rising
15.05% of float · ▲ +3.2% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
215 holders — near 3-yr high, broad support
Squeeze score
82
high risk · 0–100
Fundamentals
EPS growth
−33%
Y/Y
Free cash flow
$-186.5M
Balance sheet
$162.1M
net cash
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−2%
Neutral
Price vs 50-day avg
−3%
Neutral
RSI (14)
46
Neutral
MACD trend
Positive
Bullish
52-week position
64%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Distributing
-1% holders QoQ · +30 funds added
Insider flow
Accumulating
Net +$3.3M over 90 days · 0% sells
Short interest
Rising
15.05% of float · ▲ +3.2% MoM · 10.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
215 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $5 · 64%
Range high $7
vs 200-day avg -2%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ANNX
this stock
Annexon, Inc.
|
$1.06B | +3.2% | — | — | 15.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
ARGX
Argenx SE
|
$64.56B | +23.4% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$58.31B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ANNX | -1.5% | -2.3% | -7.5% | +1.7% | +3.2% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +0.4% | -5.6% | -18.7% | -0.4% | -8.6% |
Key facts
CIK
1528115
CUSIP
03589W102
13F (30d)
202 filings
199 filers
Visit website
Investor relations